Cited by 358Sex and Gender in HealthcareDiversity and Career in MedicineHealth and Medical Research Impacts

Studying both sexes: a guiding principle for biomedicine

Open access
Clayton, Janine Austin·2016·The FASEB Journal

Abstract

In May 2014, the U.S. National Institutes of Health (NIH) announced that it will ensure that investigators account for sex as a biological variable (SABV) in NIH‐funded preclinical research as part of the agency's rigor and transparency initiative. Herein, I describe in more detail the rationale behind the SABV policy component and provide additional detail about policy goals. In short, studying both sexes is a guiding principle in biomedical research that will expand knowledge toward turning discovery into health. NIH expects that considering SABV in preclinical research will help to build a knowledge base that better informs the design of clinical research and trials in humans. Integrating the practice of studying both sexes in preclinical research will, over time, expand our currently incomplete knowledge base that plays a critical role in informing the development of sex‐and gender‐appropriate medical care for women and men.—Clayton, J. A. Studying both sexes: a guiding principle for biomedicine. FASEB J. 30, 519‐524 (2016). www.fasebj.org

Integrity signals

Registry

Crossref · 10.1096/fj.15-279554

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some treatments that currently exist for several diseases are not adequately evaluated in women, who are likely to be underrepresented in clinical trials, especially in Phases I and II.

    “some of the treatments that currently exist for several diseases are not adequately evaluated in women27,28 who are likely to be underrepresented in clinical trials29,30, especially in Phases I and II31,32.”
  • Most researchers avoid using female animals in research, primarily because of hormonal changes across the estrus cycle.

    “For many years, the default model in human studies has been a 70 kg male [187] and most researchers avoid using female animals in research [188], primarily because of hormonal changes across the estrus cycle [187].”
  • For many years, the default model in human studies has been a 70 kg male.

    “For many years, the default model in human studies has been a 70 kg male [187] and most researchers avoid using female animals in research [188], primarily because of hormonal changes across the estrus cycle [187].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clayton, J. A.
Affiliations
National Institutes of Health (US)
Corresponding author
Clayton, Janine Austin
Venue
The FASEB Journal
Publisher
Wiley
Published
2015-10-29
Volume
30
Issue
2
Pages
519-524
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2193493665
Cited by
358
References
46
Citations by year
2026: 20 · 2025: 47 · 2024: 39 · 2023: 39 · 2022: 40 · 2021: 33 · 2020: 37 · 2019: 19 · 2018: 37 · 2017: 27 · 2016: 20
FWCI
29.96
Type
journal article
Language
en
Open access
Locations
  • The FASEB Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Social Sciences › Gender Studies › Diversity and Career in Medicine
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health and Medical Research Impacts
Keywords
sex as a biological variable, NIH policy, preclinical research, women in medicine
MeSH terms
Female, Humans, Male, National Institutes of Health (U.S.), Sex Factors, United States, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review